These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5413668)

  • 1. Serum magnesium in children with cirrhosis.
    Cohen MI; McNamara H; Finberg L
    J Pediatr; 1970 Mar; 76(3):453-5. PubMed ID: 5413668
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels of magnesium in hepatic cirrhosis].
    Pasqualetti P; Casale R; Colantonio D; Di Lauro G; Festuccia V; Natali L; Natali G
    Quad Sclavo Diagn; 1987 Mar; 23(1):12-7. PubMed ID: 3441590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
    Albert JP; Wronski R; Jentzen F; Hartmann F
    Med Klin; 1979 Sep; 74(37):1315-9. PubMed ID: 492054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum magnesium levels in children with cirrhosis.
    Kaya G; Ozsoylu S
    Acta Paediatr Scand; 1972 Jul; 61(4):442-4. PubMed ID: 5041392
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum magnesium, copper and iron levels in infantile cirrhosis.
    Vij SC; Vij A
    Indian Pediatr; 1975 May; 12(5):411-3. PubMed ID: 1158516
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum magnesium levels in Indian childhood cirrhosis.
    Sharma A; Dhatt PS; Singh H; Gupta HL
    Indian Pediatr; 1975 Feb; 12(2):161-3. PubMed ID: 1158473
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the serotonin4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism.
    Lefebvre H; Héron F; Contesse V; Delarue C; Vaudry H; Kuhn JM
    Eur J Clin Pharmacol; 1998 Feb; 53(6):479-80. PubMed ID: 9551708
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
    Bernardi M; Servadei D; Trevisani F; Rusticali AG; Gasbarrini G
    Digestion; 1985; 31(4):189-93. PubMed ID: 4007290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiological bases of the utilization of aldosterone antagonists. Their clinical applications].
    VAN CAUWENBERGE H; LEFEBVRE P
    Acta Cardiol; 1962; 17():627-56. PubMed ID: 13995980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum and CSF magnesium levels in patients with Indian childhood cirrhosis.
    Sharma A; Dhatt PS; Singh H; Gupta HL
    Indian J Med Res; 1976 Feb; 64(2):292-5. PubMed ID: 1270117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P; Guevara M; Arroyo V
    Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS].
    GARCIA RAMOSARRIAGA J
    Rev Esp Enferm Apar Dig Nutr; 1963 Oct; 22():1088-91. PubMed ID: 14112555
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
    Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
    Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum magnesium level in infants and children with hepatic diseases.
    Kobayashi A; Shiraki K
    Arch Dis Child; 1967 Dec; 42(226):615-8. PubMed ID: 6073828
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diuretics in cirrhosis. Accidents. Indications].
    Andrieu J; Lesueur G
    Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary aldosteronism and low-renin hypertension: a continuum?
    Funder JW
    Nephrol Dial Transplant; 2013 Jul; 28(7):1625-7. PubMed ID: 23535225
    [No Abstract]   [Full Text] [Related]  

  • 18. Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
    LOCKWOOD CH
    Can Med Assoc J; 1961 Sep; 85(11):631-7. PubMed ID: 13763007
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum magnesium in portal cirrhosis.
    Gupta CP; Mittal HS; Elhence GP; Singh VS; Dwivedi KK; Singh BP
    J Assoc Physicians India; 1977 Sep; 25(9):605-9. PubMed ID: 612657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spirolactone (Aldactone) in ascites caused by liver cirrhosis].
    van DOMMELEN C; LE POOLE A; VAANDRAGER H; SCHOPMAN W; WADMAN SK
    Ned Tijdschr Geneeskd; 1962 Jul; 106():1481-6. PubMed ID: 13887135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.